JILL BALLANTINE: Open Payments
NPI 1467691691 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 17 payments from 8 companies in 2025. Trend: 2023 $414 · 2024 $366 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $148 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| Recor Medical Inc | 1 | $24 |
| PFIZER INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Mannkind Corporation | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $3 |
Products named: VERQUVO, LEQVIO, CAPVAXIVE, Paradise Ultrasound Renal Denervation System, ELIQUIS, FARXIGA, AFREZZA, INSPIRE.
Industry payments across TX — which companies pay providers there.
